Figure 5.

Patients displaying Arpin low or NCKAP1 high have similar poor outcomes in breast cancer (A) Patients exhibiting high NCKAP1 have reduced MFS (log-rank test using optimal cutoff of 1.34; P=0.0037). (B) Patients exhibiting low Arpin and/or high NCKAP1 have further reduced MFS (log-rank test; P=0.000064). (C) Cox multivariate analysis of MFS shows that low Arpin and/or high NCKAP1 is an independent prognosis factor of MFS (P=0.0012). (D) χ² test indicates a significant mutual exclusion between Arpin low and NCKAP1 high groups (P=0.0027).